电离性刺激活纳米辅助剂增强瘤免疫性,并在固体瘤中增强免疫疗法的有效性
Shiyun Xian1,2, Xiaona Chen1,3, Sihang Ren1
1The First Affiliated Hospital, NHC Key Laboratory of Combined Multi-Organ Transplantation, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Zhejiang University School of Medicine, Hangzhou, P.R. China.
Cancer research
|July 11, 2024
概括
这项研究开发了一种新型纳米辅助剂,可以激活STING通路,以增强冷瘤中的抗瘤免疫力. 该纳米辅助剂在临床前癌症模型中表现出显著的疗效,提供了一个有前途的新免疫疗法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
背景情况:
- 由于缺乏炎症反应",冷"瘤对免疫疗法具有抗性.
- 激活干扰素基因刺激器 (STING) 途径可以增强先天免疫力和瘤免疫性.
- 为癌症免疫疗法开发有效的STING激动剂输送系统至关重要.
研究的目的:
- 设计一种瘤受限纳米辅助剂,激活STING通路并重塑瘤微环境.
- 在结直肠癌和三阴性乳腺癌的临床前模型中评估纳米辅助剂的疗效.
- 评估纳米辅助剂对潜在临床应用的安全性和免疫刺激作用.
主要方法:
- 通过化学工程将非核酸刺痛激素MSA-2转化为电离性前药物,并将其配制成纳米辅助剂.
- 纳米辅助剂循环保留和内输送与脂质体相比较.
- 在酸性瘤微环境中研究了纳米辅助剂的行为,包括PEG脱和内/溶酶体逃逸.
- 在大肠直肠癌和三阴性乳腺癌的小鼠模型中评估了STING激活和抗瘤免疫反应.
主要成果:
- 纳米辅助剂表现出延长的血液循环,改善了内输送和有效的瘤透.
- 纳米粒子治疗激活了STING,导致从免疫抑制转变为瘤杀伤性瘤免疫景观.
- 在结直肠和三阴性乳腺癌模型中显示出显著的抗瘤疗效,与免疫检查点抑制剂相结合时效果得到增强.
- 纳米辅助剂耐受性良好,并诱导了持久的抗瘤免疫反应.
结论:
- 通过电离性前药方法设计的STING激活纳米辅助剂在全身管理中是安全和有效的.
- 这种纳米辅助剂代表了一种有前途的免疫治疗策略,以克服"冷"瘤耐药性并改善癌症治疗结果.
- 需要对这种STING纳米辅助剂单独或与其他免疫疗法结合进行进一步的临床评估.
相关概念视频
01:27Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
01:30Cancer Vaccines
350
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
350
01:26Antigens Involved in Adaptive Immunity
482
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
482
01:27Cytotoxic T Cells-mediated Immune Response
886
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
886